AKT1 and breast cancer: These findings collectively indicate that treatment with flubendazole in MCF-7/PTX cells leads to varying degrees of inhibition in the proliferation and metastasis of BC cells, accompanied by diverse reductions in the expression of the PI3K/AKT signaling pathway.